Provided by Tiger Trade Technology Pte. Ltd.

Haemonetics

55.93
-0.7300-1.29%
Post-market: 55.930.00000.00%16:10 EDT
Volume:495.60K
Turnover:27.67M
Market Cap:2.60B
PE:15.32
High:57.72
Open:57.11
Low:55.12
Close:56.66
52wk High:87.32
52wk Low:47.32
Shares:46.47M
Float Shares:46.47M
Volume Ratio:0.63
T/O Rate:1.07%
Dividend:- -
Dividend Rate:- -
EPS(TTM):3.65
EPS(LYR):3.31
ROE:19.30%
ROA:6.45%
PB:2.85
PE(LYR):16.90

Loading ...

Data Supporting the Potentially Differentiated Pharvaris Portfolio Presented at ACAAI 2025 Annual Scientific Meeting

GlobeNewswire
·
Nov 10, 2025

Haemonetics Corp : Mizuho Raises Target Price to $75 From $65

THOMSON REUTERS
·
Nov 10, 2025

Intellia Therapeutics Presents Positive Pooled Phase 1/2 Data of Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema

GlobeNewswire
·
Nov 09, 2025

BUZZ-U.S. STOCKS ON THE MOVE-Novo Nordisk, Block, Peloton Interactive

Reuters
·
Nov 08, 2025

Haemonetics Taking Prudent View on Guidance After Plasma Recovery, BofA Says

MT Newswires Live
·
Nov 08, 2025

BUZZ-Haemonetics rises after BofA upgrades to "neutral" on prudent growth forecast

Reuters
·
Nov 07, 2025

Stock Track | Haemonetics Soars 5.27% as Needham Raises Price Target to $78

Stock Track
·
Nov 07, 2025

Haemonetics Corp : Bofa Global Research Raises to Neutral From Underperform; Raises Price Objective to $75 From $58

THOMSON REUTERS
·
Nov 07, 2025

Haemonetics upgraded to Neutral from Underperform at BofA

TIPRANKS
·
Nov 07, 2025

Needham Raises Price Target on Haemonetics to $78 From $68, Keeps Buy Rating

MT Newswires Live
·
Nov 07, 2025

U.S. RESEARCH ROUNDUP-Blackline, Carmax, Expedia

Reuters
·
Nov 07, 2025

Stock Track | Haemonetics Soars 33.75% on Strong Q2 Earnings Beat and Raised Guidance

Stock Track
·
Nov 07, 2025

Haemonetics: Strong Financial Performance and Strategic Adjustments Drive Buy Rating

TIPRANKS
·
Nov 07, 2025

Sector Update: Health Care Stocks Softer in Afternoon Trading

MT Newswires Live
·
Nov 07, 2025

Haemonetics Is Maintained at Buy by BTIG

Dow Jones
·
Nov 07, 2025

Haemonetics Shares Gain on Higher 2Q Profit, Outlook Boost

Dow Jones
·
Nov 07, 2025

Haemonetics price target raised to $88 from $85 at BTIG

TIPRANKS
·
Nov 07, 2025

Haemonetics rises 26.1%

TIPRANKS
·
Nov 07, 2025

Update: Haemonetics Shares Rise After Fiscal Q2 Results Top Expectations

MT Newswires Live
·
Nov 07, 2025

Stock Track | Haemonetics Soars 16.32% as Q2 Earnings Smash Expectations, Company Raises Guidance

Stock Track
·
Nov 06, 2025